Skip to main content

Table 5 Multivariate analysis of rs1042522 on survival in 136 patients treated with CHOP or CHOP-like therapy

From: TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

Variable

Hazard ratio

95% CIs

P

GCB/Non-GCB

0.316

0.158–0.633

0.001

IPI score

4.218

2.235–7.962

0.000

GG + GC/CC

0.343

0.173–0.679

0.002

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us